| (Values in U.S. Thousands) | Dec, 2020 | Dec, 2019 | Dec, 2018 | Feb, 2026 | Feb, 2026 |
| Sales | 8,780 | 970 | 0 | 0 | 0 |
| Sales Growth | +805.15% | unch | unch | unch | unch |
| Net Income | -38,110 | -21,880 | 0 | 0 | 0 |
| Net Income Growth | -74.18% | unch | unch | unch | unch |
Pandion Therapeutics Inc
(PAND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Pandion Therapeutics Inc. is a biotechnology company. It focuses on developing modular proteins, antibodies and bispecifics for the treatment of autoimmune and inflammatory diseases. Pandion Therapeutics Inc. is based in North Cambridge, United States.
Fiscal Year End Date: 12/31